Working backwards on this one, I first had it from Roy Poses' "Health Care Renewal" blog that referred me to a blog by Alison Bass:
Which in turn quoted the Boston Globe:
Here's the quick scoop--Massachusetts recently, as part of its efforts to cut health care costs to accommodate its new health reform law mandating insurance coverage for most residents, passed a strict law limiting financial relationships between drug companies and medical activities. Though the final rules have not yet been put in place, three medical professional societies have announced plans to switch their major CME meetings out of Boston, claiming that the new law will unduly restrict presentations given by drug company scientists. The organizations are the American Academy of Allergy, Asthma and Immunology, the American Society for Gene Therapy, and the Heart Rhythm Society.
Defenders of the new law say that there will actually be no such restrictions on which scientists can speak at meeting and that the move amounts to fear-mongering on the part of the societies. Bass goes beyond the Globe article by pointing out who bankrolls the three societies, and notes that major bioetech and pharma interests that were opposed to the new law are heavy funders.
So now we have the spectacle, not only of supposedly "professional" medical societies taking lots of dough from industry regardless of the conflicts of interest that this poses, but of the societies then proceeding to carry the lobbying water for those companies, making the industry's cause their own. A pretty sorry statement for "professional" advocacy and ethics.